{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:15:00Z","timestamp":1791288900196,"version":"4.3.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T00:00:00Z","timestamp":1713139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T00:00:00Z","timestamp":1713139200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"OncoNano Medicine"},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1245\/s10434-024-15165-4","type":"journal-article","created":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T17:01:33Z","timestamp":1713200493000},"page":"4726-4734","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Detection of Residual Peritoneal Metastases Following Cytoreductive Surgery Using Pegsitacianine, a pH-Sensitive Imaging Agent: Final Results from a Phase II Study"],"prefix":"10.1245","volume":"31","author":[{"given":"Patrick","family":"Wagner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward A.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex C.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perry","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole D.","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon N.","family":"Westin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurel K.","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgos C.","family":"Karakousis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janos L.","family":"Tanyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeline T.","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Madajewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Ostrander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kartik","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles M.","family":"Balch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Bartlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,15]]},"reference":[{"issue":"1","key":"15165_CR1","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41572-021-00326-6","volume":"7","author":"D Cortes-Guiral","year":"2021","unstructured":"Cortes-Guiral D, Hubner M, Alyami M, et al. Primary and metastatic peritoneal surface malignancies. Nat Rev Dis Primers. 2021;7(1):91. https:\/\/doi.org\/10.1038\/s41572-021-00326-6.","journal-title":"Nat Rev Dis Primers."},{"issue":"24","key":"15165_CR2","doi-asserted-by":"publisher","first-page":"5608","DOI":"10.1002\/cncr.25356","volume":"116","author":"O Glehen","year":"2010","unstructured":"Glehen O, Gilly FN, Boutitie F, et al. Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1,290 patients. Cancer. 2010;116(24):5608\u201318. https:\/\/doi.org\/10.1002\/cncr.25356.","journal-title":"Cancer."},{"issue":"4","key":"15165_CR3","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.jamcollsurg.2013.12.013","volume":"218","author":"EA Levine","year":"2014","unstructured":"Levine EA, Stewart JHT, Shen P, Russell GB, Loggie BL, Votanopoulos KI. Intraperitoneal chemotherapy for peritoneal surface malignancy: experience with 1,000 patients. J Am Coll Surg. 2014;218(4):573\u201385. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2013.12.013.","journal-title":"J Am Coll Surg."},{"issue":"9","key":"15165_CR4","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/nrc3566","volume":"13","author":"QT Nguyen","year":"2013","unstructured":"Nguyen QT, Tsien RY. Fluorescence-guided surgery with live molecular navigation\u2013a new cutting edge. Nat Rev Cancer. 2013;13(9):653\u201362. https:\/\/doi.org\/10.1038\/nrc3566.","journal-title":"Nat Rev Cancer."},{"key":"15165_CR5","doi-asserted-by":"publisher","first-page":"314","DOI":"10.3389\/fonc.2017.00314","volume":"7","author":"T Nagaya","year":"2017","unstructured":"Nagaya T, Nakamura YA, Choyke PL, Kobayashi H. Fluorescence-guided surgery. Front Oncol. 2017;7:314. https:\/\/doi.org\/10.3389\/fonc.2017.00314.","journal-title":"Front Oncol."},{"issue":"31","key":"15165_CR6","doi-asserted-by":"publisher","first-page":"11085","DOI":"10.1021\/ja5053158","volume":"136","author":"X Ma","year":"2014","unstructured":"Ma X, Wang Y, Zhao T, et al. Ultra-pH-sensitive nanoprobe library with broad pH tunability and fluorescence emissions. J Am Chem Soc. 2014;136(31):11085\u201392. https:\/\/doi.org\/10.1021\/ja5053158.","journal-title":"J Am Chem Soc."},{"key":"15165_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16814-4","author":"FJ Voskuil","year":"2020","unstructured":"Voskuil FJ, Steinkamp PJ, Zhao T, et al. Exploiting metabolic acidosis in solid cancers using a tumor-agnostic pH-activatable nanoprobe for fluorescence-guided surgery. Nat Comm. 2020. https:\/\/doi.org\/10.1038\/s41467-020-16814-4.","journal-title":"Nat Comm."},{"issue":"1","key":"15165_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1477-7800-2-3","volume":"2","author":"RL Harmon","year":"2005","unstructured":"Harmon RL, Sugarbaker PH. Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer. Int Semin Surg Oncol. 2005;2(1):3. https:\/\/doi.org\/10.1186\/1477-7800-2-3.","journal-title":"Int Semin Surg Oncol."},{"key":"15165_CR9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.00291","author":"JL Tanyi","year":"2022","unstructured":"Tanyi JL, Randall LM, Chambers SK, et al. A phase III study of pafolacianine injection (OTL38) for intraoperative imaging of folate receptor-positive ovarian cancer (study 006). J Clin Oncol. 2022. https:\/\/doi.org\/10.1200\/JCO.22.00291.","journal-title":"J Clin Oncol."},{"key":"15165_CR10","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2200333","author":"BL Smith","year":"2023","unstructured":"Smith BL, Hunt KK, Carr D, et al. Intraoperative fluorescence guidance for breast cancer lumpectomy surgery. NEJM Evidence. 2023. https:\/\/doi.org\/10.1056\/EVIDoa2200333.","journal-title":"NEJM Evidence."},{"issue":"1","key":"15165_CR11","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3322\/caac.21749","volume":"73","author":"JM Foster","year":"2023","unstructured":"Foster JM, Zhang C, Rehman S, Sharma P, Alexander HR. The contemporary management of peritoneal metastasis: a journey from the cold past of treatment futility to a warm present and a bright future. CA Cancer J Clin. 2023;73(1):49\u201371. https:\/\/doi.org\/10.3322\/caac.21749.","journal-title":"CA Cancer J Clin."},{"issue":"2","key":"15165_CR12","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/cncr.23553","volume":"113","author":"A Di Giorgio","year":"2008","unstructured":"Di Giorgio A, Naticchioni E, Biacchi D, et al. Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer. Cancer. 2008;113(2):315\u201325.","journal-title":"Cancer."},{"issue":"2","key":"15165_CR13","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.ygyno.2012.02.024","volume":"125","author":"SJ Chang","year":"2012","unstructured":"Chang SJ, Bristow RE. Evolution of surgical treatment paradigms for advanced-stage ovarian cancer: redefining \u201coptimal\u201d residual disease. Gynecol Oncol. 2012;125(2):483\u201392. https:\/\/doi.org\/10.1016\/j.ygyno.2012.02.024.","journal-title":"Gynecol Oncol."},{"issue":"3","key":"15165_CR14","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s13193-016-0518-0","volume":"7","author":"PH Sugarbaker","year":"2016","unstructured":"Sugarbaker PH. Preoperative assessment of cancer patients with peritoneal metastases for complete cytoreduction. Indian J Surg Oncol. 2016;7(3):295\u2013302. https:\/\/doi.org\/10.1007\/s13193-016-0518-0.","journal-title":"Indian J Surg Oncol."},{"issue":"5","key":"15165_CR15","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1002\/1097-0142(19930901)72:5<1631::AID-CNCR2820720523>3.0.CO;2-I","volume":"72","author":"PF Jacquet","year":"1993","unstructured":"Jacquet PF, Jelinek JS, Steves MA, Sugarbaker PH. Evaluation of computed tomography in patients with peritoneal carcinomatosis. Cancer. 1993;72(5):1631\u20136.","journal-title":"Cancer."},{"issue":"2","key":"15165_CR16","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.ejso.2014.09.008","volume":"41","author":"T Abo","year":"2015","unstructured":"Abo T, Nanashima A, Tobinaga S, et al. Usefulness of intraoperative diagnosis of hepatic tumors located at the liver surface and hepatic segmental visualization using indocyanine green-photodynamic eye imaging. Eur J Surg Oncol (EJSO). 2015;41(2):257\u201364. https:\/\/doi.org\/10.1016\/j.ejso.2014.09.008.","journal-title":"Eur J Surg Oncol (EJSO)."},{"issue":"7","key":"15165_CR17","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1007\/s00464-014-3895-x","volume":"29","author":"L Boni","year":"2015","unstructured":"Boni L, David G, Mangano A, et al. Clinical applications of indocyanine green (ICG) enhanced fluorescence in laparoscopic surgery. Surg Endosc. 2015;29(7):2046\u201355. https:\/\/doi.org\/10.1007\/s00464-014-3895-x.","journal-title":"Surg Endosc."},{"issue":"2","key":"15165_CR18","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1055\/s-0037-1606536","volume":"34","author":"K Li","year":"2018","unstructured":"Li K, Zhang Z, Nicoli F, et al. Application of indocyanine green in flap surgery: a systematic review. J Reconstr Microsurg. 2018;34(2):77\u201386. https:\/\/doi.org\/10.1055\/s-0037-1606536.","journal-title":"J Reconstr Microsurg."},{"issue":"9","key":"15165_CR19","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1136\/ijgc-2020-001584","volume":"30","author":"R Nitecki","year":"2020","unstructured":"Nitecki R, Rauh-Hain JA, Melamed A, et al. Laparoscopic cytoreduction After Neoadjuvant ChEmotherapy (LANCE). Int J Gynecol Cancer. 2020;30(9):1450\u20134. https:\/\/doi.org\/10.1136\/ijgc-2020-001584.","journal-title":"Int J Gynecol Cancer."},{"issue":"9","key":"15165_CR20","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1136\/ijgc-2019-000971","volume":"29","author":"A Melamed","year":"2019","unstructured":"Melamed A, Rauh-Hain JA. Minimally invasive interval cytoreductive surgery: it\u2019s time for a randomized trial. Int J Gynecol Cancer. 2019;29(9):1339\u201340. https:\/\/doi.org\/10.1136\/ijgc-2019-000971.","journal-title":"Int J Gynecol Cancer."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-15165-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-024-15165-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-15165-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T20:13:29Z","timestamp":1718050409000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-024-15165-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,15]]},"references-count":20,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["15165"],"URL":"https:\/\/doi.org\/10.1245\/s10434-024-15165-4","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,15]]},"assertion":[{"value":"4 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Shannon Westin received grants\/contracts to institution from Astra Zeneca, AvengeBio, Bayer, Bio-Path, Clovis Oncology, GSK, Jazz Pharmaceuticals, Mereo, Novartis, Nuvectis, Roche\/Genentech, and Zentalis and consulted for AstraZeneca, Caris, Clovis Oncology, Eisai, EQRX, Gilead, GSK, Immunocore, ImmunoGen, Lilly, Merck, Mereo, Mersana, NGM Bio, Nuvectis, Roche\/Genentech, SeaGen, Verastem, Vincerx, Zentalis, and ZielBio; Dr. Giorgos Karakousis received research support from industry to fund clinical trial at institution; Mr. Brian Madajewski is the holder of intellectual property in the form of patents and copyrights (Hall K.A.; Madajewski B; Kaplan H; \u201cpH Responsive Compositions, Formulations, and Methods of Imaging a Tumor\u201d 2020, United States patent appl.62\/937141, 18 November 2020); Dr. Charles Balch is the chair of the Scientific Advisory Board of OncoNano Medicine and invested in OncoNano stock; and Dr. David Bartlett was responsible for the clinical trial patient enrollment fee being negotiated between AHN and OncoNano. The authors acknowledge support from the Cancer Research and Prevention Institute of Texas, OncoNano Medicine.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}